We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| BG Medicine Inc (CE) | USOTC:BGMD | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000129 | 12,900.00% | 0.00013 | 0.00013 | 0.00013 | 0.00013 | 155 | 19:07:18 |
From Jul 2019 to Jul 2024
Conference Call Details
The conference call may be accessed by dialing (877) 845-1016 from the U.S. and Canada, or (708) 290-1155 from international locations. The conference call will also be available via the internet at www.bg-medicine.com.
Listeners are encouraged to login at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software.
To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's website at www.bg-medicine.com. Please connect to the website at least 15 minutes prior to the call to download and install any necessary audio software.
About BG Medicine
BG Medicine Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit www.bg-medicine.com.
The BG Medicine Inc. logo is available for download here.
Hot Features
Premium
CONTACT: Steve Hall
EVP & Chief Financial Officer
(781) 890-1199
1 Year BG Medicine (CE) Chart |
1 Month BG Medicine (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
